Most popular programs
Trending now
Cell therapies, such as CAR-T and stem cell therapies, are an exciting new class of therapeutics with the potential to revolutionize medicine. Learn the biology, engineering, and analytical chemistry behind how these amazing new products are manufactured.
The success of CAR-T cell therapies, driven by their unprecedented efficacy and recent regulatory approvals, has kick-started a new wave of interest into cells as therapies. Yet manufacturing is the link between an exciting new development in the laboratory and a commercial therapy available to the patients who need it. This course will introduce learners to this new field through the following topics.
This course is intended to provide an overview of the key concepts needed to manufacture a cell therapy for learners interested in entering this exciting new field.
Cell Biology
Vice President for Research & Innovation; Professor, Department of Materials Science & Engineering and Meinig School of Biomedical Engineering • Cornell University
Class of 1956 Career Development Professor, Biological Engineering • Massachusetts Institute of Technology
Co-Director, Biomanufacturing Program • Massachusetts Institute of Technology
Who can take this course?
Unfortunately, learners residing in one or more of the following countries or regions will not be able to register for this course: Iran, Cuba and the Crimea region of Ukraine. While edX has sought licenses from the U.S. Office of Foreign Assets Control (OFAC) to offer our courses to learners in these countries and regions, the licenses we have received are not broad enough to allow us to offer this course in all locations. edX truly regrets that U.S. sanctions prevent us from offering all of our courses to everyone, no matter where they live.
Who can take this course?
Unfortunately, learners residing in one or more of the following countries or regions will not be able to register for this course: Iran, Cuba and the Crimea region of Ukraine. While edX has sought licenses from the U.S. Office of Foreign Assets Control (OFAC) to offer our courses to learners in these countries and regions, the licenses we have received are not broad enough to allow us to offer this course in all locations. edX truly regrets that U.S. sanctions prevent us from offering all of our courses to everyone, no matter where they live.